TP53 and breast carcinoma: Women who carried TP53 PVs were diagnosed with breast cancer at a statistically significant younger age compared to non-carriers (mean [SD] age: 24.75 [3.00] vs. 27.31 [2.75] years, p << 0.01, respectively).